MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pharmacyclics Company Profile (NASDAQ:PCYC)

Consensus Ratings for Pharmacyclics (NASDAQ:PCYC) (?)
Ratings Breakdown: 16 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.24)
Consensus Price Target: $209.24 (19.91% downside)

Current Analysts' Coverage Summary for Pharmacyclics (NASDAQ:PCYC)
Show:
DateFirmActionRatingPrice TargetActions
5/29/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015BMO Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Credit SuisseReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015WallachBeth CapitalBoost Price TargetHold$222.00 -> $261.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015Piper JaffraySet Price TargetHold$184.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015NomuraDowngradeBuy -> Neutral$196.00 -> $261.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015Wells Fargo & Co.DowngradeOutperform -> Market Perform$261.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015RBC CapitalBoost Price TargetSector Perform$145.00 -> $261.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015WedbushDowngradeOutperform -> Neutral$225.00 -> $234.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Goldman SachsDowngradeHold$184.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Robert W. BairdBoost Price Target$240.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Deutsche BankDowngradeBuy -> Hold$235.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Stifel NicolausReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$152.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Roth CapitalDowngradeBuy -> Neutral$189.00 -> $187.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2015Citigroup Inc.Boost Price TargetBuy$145.00 -> $155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014JMP SecuritiesReiterated RatingMarket Outperform$200.00 -> $204.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Morgan StanleyReiterated RatingEqual Weight$103.00 -> $111.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014William BlairBoost Price Target$186.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014SunTrustInitiated CoverageNeutral$140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Lazard Capital MarketsReiterated RatingBuy$141.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/5/2013 forward)